Platypnea-Orthodeoxia Syndrome

 

Platypnea-Orthodeoxia Syndrome: A Comprehensive Review for the Internist

Dr Neeraj Manikath , claude.ai

Abstract

Platypnea-orthodeoxia syndrome (POS) represents a rare but clinically significant constellation of positional dyspnea and hypoxemia that worsens in the upright position and improves when supine. This paradoxical phenomenon challenges our conventional understanding of respiratory physiology and demands heightened clinical suspicion for timely diagnosis. This review synthesizes current understanding of pathophysiology, diagnostic approaches, and management strategies, with practical clinical pearls for the practicing internist.

Introduction

The term "platypnea" derives from the Greek words platys (flat) and pnoia (breath), literally meaning "flat breathing." First described by Burchell et al. in 1949, platypnea refers to dyspnea that is relieved by recumbency and exacerbated by upright posture—the opposite of orthopnea. When accompanied by arterial oxygen desaturation in the upright position (orthodeoxia), this constitutes platypnea-orthodeoxia syndrome. Despite being described over seven decades ago, POS remains underrecognized, leading to diagnostic delays averaging 1-2 years in many case series.

Pathophysiological Mechanisms

Understanding POS requires appreciation of three primary mechanisms: intracardiac shunting, intrapulmonary shunting, and ventilation-perfusion mismatch.

Intracardiac Shunting

Patent foramen ovale (PFO) represents the most common anatomical substrate for POS, present in approximately 25% of the general population. However, PFO alone is insufficient; a functional component must coexist. The development of symptoms requires both an anatomical defect and a functional mechanism that creates a pressure gradient favoring right-to-left shunting in the upright position.

Several conditions create this functional component. Prominent Eustachian valve or Chiari network can preferentially direct inferior vena cava blood toward the PFO. Ascending aortic dilation or elongation, particularly following aortic root replacement, can mechanically distort atrial geometry, redirecting flow toward the interatrial septum. Pericardial effusion or constrictive physiology may alter chamber compliance and pressure relationships.

Clinical Pearl: In patients with prior aortic root surgery presenting with unexplained hypoxemia, always consider POS. The geometric distortion from ascending aortic replacement can unmask a previously asymptomatic PFO.

Intrapulmonary Shunting

Hepatopulmonary syndrome (HPS) exemplifies intrapulmonary vascular dilatation leading to POS. The pathophysiology involves release of vasodilators that preferentially dilate precapillary and capillary vessels in gravity-dependent lung bases. In the upright position, increased perfusion to these dilated vessels, combined with limited time for oxygen diffusion across the widened capillary bed, creates significant shunting.

Arteriovenous malformations, whether congenital or acquired, can similarly produce positional hypoxemia when located in the lung bases. The increased perfusion to dependent regions in the upright posture worsens shunting through these abnormal vessels.

Ventilation-Perfusion Mismatch

Certain parenchymal and vascular conditions create positional V/Q mismatch. Extensive bilateral lower lobe disease (fibrosis, pneumonia, atelectasis) receives increased perfusion when upright while ventilation remains compromised. Post-pneumonectomy patients may develop shunting through residual lung if vascular remodeling creates low-resistance pathways. Pulmonary arteriovenous malformations in the lower lobes become more perfused when upright, worsening shunting.

Oyster: Not all positional dyspnea is platypnea. Orthopnea from heart failure or bendopnea from elevated filling pressures represents different physiology entirely. True platypnea improves when lying flat—a key distinguishing feature.

Clinical Presentation and Recognition

The classic presentation involves a patient reporting worsening dyspnea and sometimes lightheadedness or fatigue when standing or sitting upright, with relief upon reclining. However, presentations vary considerably in subtlety.

Diagnostic Clues

Patients may describe preferring to lie flat throughout the day—unusual behavior that should prompt consideration of POS. Some report positional cyanosis, particularly of the lips or nail beds when upright. Others note exercise intolerance out of proportion to their cardiac or pulmonary function testing.

Historical factors suggesting increased risk include:

• Recent cardiac surgery, particularly aortic root procedures
• Known or suspected liver disease (HPS)
• History of stroke, especially cryptogenic
• Prior pulmonary embolism with persistent dyspnea
• Chronic lung disease with unexplained worsening

Clinical Hack: Perform pulse oximetry in both supine and standing positions during the initial evaluation of any patient with unexplained dyspnea. A drop of ≥5% or ≥5 mmHg in arterial PO₂ constitutes significant orthodeoxia and warrants investigation.

Diagnostic Approach

Initial Assessment

The diagnostic evaluation begins with documentation of positional changes in oxygenation. Perform pulse oximetry or arterial blood gas analysis both supine (after 5-10 minutes of recumbency) and upright (after 5 minutes of standing or sitting). Orthodeoxia is typically defined as a decrease in PaO₂ of ≥5 mmHg or oxygen saturation of ≥4-5% when moving from supine to upright.

Imaging Studies

Transthoracic echocardiography with agitated saline (bubble study) serves as the initial screening test for intracardiac shunting. Perform the study in both supine and upright positions, as some shunts only manifest positionally. Appearance of bubbles in the left atrium within 3-5 cardiac cycles suggests intracardiac shunting through a PFO or atrial septal defect. Later appearance (>5 cycles) indicates intrapulmonary shunting.

Pearl: Request a standing or sitting bubble study specifically if initial supine study is negative but clinical suspicion remains high. Many echocardiography laboratories routinely perform only supine imaging.

Transesophageal echocardiography provides superior visualization of the interatrial septum, PFO anatomy, and associated structures like Eustachian valves or Chiari networks. It remains the gold standard for characterizing intracardiac shunts.

Contrast-enhanced echocardiography can help differentiate intracardiac from intrapulmonary shunting based on timing of left heart opacification.

Advanced Imaging

Chest computed tomography with contrast helps identify pulmonary arteriovenous malformations, parenchymal disease, or vascular abnormalities. In suspected HPS, technetium-99m macroaggregated albumin scanning can detect and quantify intrapulmonary shunting.

Cardiac MRI may reveal structural abnormalities, including atrial septal anatomy and aortic root geometry, particularly useful in post-surgical patients.

Physiological Testing

Right heart catheterization can document pressure gradients and directly measure shunt fraction. It proves especially valuable when non-invasive testing is inconclusive or multiple mechanisms may coexist.

Oyster: Hypoxemia that improves with 100% oxygen suggests V/Q mismatch rather than true shunting. Persistent hypoxemia despite high FiO₂ indicates significant shunt physiology—an important distinction guiding therapy.

Differential Diagnosis

Several conditions mimic or overlap with POS:

Orthostatic intolerance syndromes may cause dyspnea when upright but lack objective hypoxemia. Deconditioning produces exertional dyspnea but not resting positional hypoxemia. Anxiety and hyperventilation can cause positional symptoms but typically increase rather than decrease oxygen saturation.

Autonomic dysfunction may cause both positional dyspnea and apparent oxygen desaturation (due to poor peripheral perfusion), but arterial blood gas analysis reveals normal PaO₂.

Management Strategies

Treatment depends on the underlying mechanism identified.

Intracardiac Shunts

Percutaneous PFO closure represents definitive therapy for patients with PFO-associated POS. Success rates exceed 90% in appropriately selected patients, with symptom resolution typically occurring within days to weeks. Device options include the Amplatzer PFO Occluder, HELEX Septal Occluder, and other approved devices.

Patient selection requires confirming that the PFO causes symptoms and excluding other contributing factors. Severe pulmonary hypertension represents a relative contraindication, as closing the PFO may worsen right heart function by eliminating a "pop-off" mechanism.

Hack: In patients with both PFO and anatomical contributors (e.g., prominent Eustachian valve), PFO closure alone often suffices as the anatomical variants lose clinical significance once the shunt is eliminated.

Hepatopulmonary Syndrome

Management focuses on treating underlying liver disease. Definitive therapy for HPS is liver transplantation, which reverses the pulmonary vascular abnormalities in most patients, though recovery may take 6-12 months. Medical therapies including garlic derivatives, pentoxifylline, and inhaled nitric oxide have shown limited efficacy in small studies but lack robust evidence.

Supplemental oxygen improves symptoms and quality of life while awaiting transplantation. Importantly, HPS presence may increase priority for liver transplantation allocation in some regions.

Pearl: Document HPS severity with upright and supine arterial blood gases. This objective data helps with transplant listing and insurance authorization for supplemental oxygen.

Intrapulmonary Shunts

Pulmonary arteriovenous malformations require embolization when feeding arteries exceed 2-3 mm in diameter. This threshold balances stroke prevention against procedural risk. Multiple malformations may require staged procedures.

Ventilation-Perfusion Mismatch

Management addresses the underlying parenchymal disease when possible. Supplemental oxygen provides symptomatic relief. In refractory cases, body position modification (avoiding upright posture when possible) may help, though this significantly impacts quality of life.

Special Populations

Post-Cardiac Surgery

POS develops in 0.5-2% of patients following cardiac surgery, particularly after aortic root or valve procedures. The altered cardiac geometry may redirect caval flow toward a previously hemodynamically insignificant PFO. Diagnosis requires high clinical suspicion, as symptoms may be attributed to surgical recovery.

Elderly Patients

Age-related changes in thoracic anatomy, including progressive thoracic kyphosis and aortic elongation, may predispose to late-onset POS even without intervening cardiac surgery. Consider this diagnosis in elderly patients with new dyspnea and preserved cardiac function.

Pregnancy and Puerperium

Hemodynamic changes during pregnancy can unmask POS, typically in the second or third trimester when cardiac output peaks. Diagnosis becomes critical as maternal hypoxemia threatens fetal well-being. Percutaneous PFO closure has been performed safely during pregnancy in severe cases, though timing requires careful consideration.

Prognosis and Long-term Outcomes

With appropriate diagnosis and treatment, prognosis is generally excellent. Following PFO closure for POS, most patients experience complete or near-complete symptom resolution with low complication rates (major complications <2%). Recurrence is rare, typically related to residual shunting through incomplete device endothelialization or device erosion.

For HPS, prognosis correlates with ability to receive liver transplantation. Post-transplant survival in HPS patients approaches that of other transplant indications, though baseline hypoxemia severity affects perioperative risk.

Untreated POS significantly impairs quality of life and may predispose to complications including paradoxical embolism with cryptogenic stroke, brain abscess, and progressive exercise intolerance.

Clinical Pearls Summary

1. Always check oxygen saturation standing and supine in patients with unexplained dyspnea
2. Think post-cardiac surgery when evaluating new hypoxemia after aortic procedures
3. Request positional bubble studies explicitly, as standard protocols may only include supine imaging
4. Consider HPS in any patient with liver disease and unexplained hypoxemia
5. PFO closure works - don't delay referral once diagnosis is confirmed
6. Document everything positionally - symptoms, oxygen saturation, and blood gases

Future Directions

Ongoing research explores several areas: improved risk stratification for determining which PFOs warrant closure, novel device technologies with lower complication rates, and better understanding of the anatomical and physiological factors predisposing to symptomatic shunting. Advanced imaging techniques including 4D flow MRI may better characterize flow dynamics predisposing to POS.

Conclusion

Platypnea-orthodeoxia syndrome represents a diagnostic challenge requiring high clinical suspicion, systematic evaluation, and mechanistic thinking. While rare, POS is likely underdiagnosed, and recognition offers the opportunity for definitive treatment with excellent outcomes. Internists should maintain awareness of this syndrome, particularly in post-cardiac surgery patients, those with liver disease, and anyone presenting with unexplained positional dyspnea. Simple bedside maneuvers—checking oxygen saturation in different positions—can provide the first clue to this treatable cause of dyspnea.

---

Selected References

1. Burchell HB, Helmholz HF, Wood EH. Reflex orthostatic dyspnea associated with pulmonary hypotension. Am J Physiol. 1949;159:563-564.

2. Agrawal A, Palkar A, Talwar A. The multiple dimensions of platypnea-orthodeoxia syndrome: a review. Respir Med. 2017;129:31-38.

3. Blanche C, Noble S, Roffi M, et al. Platypnea-orthodeoxia syndrome in the elderly treated by percutaneous patent foramen ovale closure: a case series and literature review. Eur J Intern Med. 2013;24(8):813-817.

4. Martínez-Sellés M, García-Fernández MA. Platypnea-orthodeoxia syndrome: review of pathophysiology, clinical presentation, diagnosis and management. J Cardiovasc Med. 2020;21(3):157-161.

5. Falanga G, Carerj S, Oreto G, Khandheria BK. Platypnea-orthodeoxia syndrome: a comprehensive review. Cardiology. 2015;132(4):196-203.

6. Khosla A, Hayes R, Hirsch A, Rampersad P. Hepatopulmonary syndrome and platypnea-orthodeoxia syndrome. Clin Liver Dis. 2019;23(3):415-432.

7. Machuca TN, Mercier O, Collaud S, et al. Outcomes of transplantation for hepatopulmonary syndrome in the MELD era. Arch Surg. 2010;145(6):575-582.

8. Seward JB, Hayes DL, Smith HC, et al. Platypnea-orthodeoxia: clinical profile, diagnostic workup, management, and report of seven cases. Mayo Clin Proc. 1984;59(4):221-231.

9. Strunk BL, Cheitlin MD. Patent foramen ovale: a structural basis for platypnea-orthodeoxia in cryptogenic stroke patients. Am J Cardiol. 1992;69(19):1651-1652.

10. Zorzi A, Martelli M, Perazzolo Marra M, et al. Platypnea-orthodeoxia syndrome: a rare cause of positional dyspnea. Circulation. 2014;129(14):1492-1493.